|
| Clinical study on the therapy for acute cerebral infarction with Huatan Tongluo combined with urokinase thrombolysis |
| Hits 1933 Download times 1879 Received:October 20, 2009 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2010.01.06 |
| Key Words
acute cerebral infarction;Huatan Tongluo;thrombolysis;clinical study |
| Author Name | Affiliation | | ZHANG Yu-lian | The Second Hospital Affiliated to Tianjin University of TCM, Tianjin 300150, China | | ZHOU zhen | The Second Hospital Affiliated to Tianjin University of TCM, Tianjin 300150, China | | GUO Jia-kui | The Second Hospital Affiliated to Tianjin University of TCM, Tianjin 300150, China | | 张连城 | The Second Hospital Affiliated to Tianjin University of TCM, Tianjin 300150, China | | 王占奎 | The Second Hospital Affiliated to Tianjin University of TCM, Tianjin 300150, China | | 崔远武 | The Second Hospital Affiliated to Tianjin University of TCM, Tianjin 300150, China |
|
| Abstract
|
| [Objective] To evaluate the therapeutic effect of the of Chinese medicine combined with urokinase on acute cerebral infarction.[Methods] Based on the enrolled criteria sixty patients with acute cerebral infarction were randomly divided into the experiment and the control groups.Both groups were continuously given urokinase for three days.After that,the Huatan Tongluo (resolving phlegm and dredging collateral) medication was administered only in the experiment group for 14 days one dose a day.The NIHSS,Barthel Index(BI)and modified Rankin Scale (mRS) were analyzed for all subjects.[Results] The experiment group showed superiority in improving the scores of NIHSS and Barthel index compared to the control group (P<0.05);Based on the evaluating of MRS the experiment group was superior to the control group although no significant statistic difference was found (P>0.05).[Conclusion] The Huatan Tongluo combined with urokinase can improve the neural function and the living quality of the patients with cerebral infarction.It is believed that the Chinese medicine combined with urokinase is effective on patients with acute cerebral infarction and is superior to the therapy of urokinase only. |
|
|
|
|
|
|
|
